Mindray to Highlight New Arterial Stiffness Measurement Technology on the Resona 7 Ultrasound System at Society of Vascular Ultrasound Annual Meeting

Friday, August 3, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

ZONE Sonography® Technology Enables New Tool to Aid in Diagnosing Cardiovascular Disease

SAN JOSE, Calif., Aug. 2, 2018 /PRNewswire-PRWeb/ -- Mindray, a developer of next generation medical technology, will

be featuring its premium Resona 7 Ultrasound system with unique new upgrades at the Society of Vascular Ultrasound annual conference being held August 2-4, 2018 in San Antonio, Texas. Based on ZONE Sonography® Technology (ZST), the upgrades include a unique arterial stiffness measurement, which uses radiofrequency data-based quantitative analysis on vessel stiffness, R-VQS.

"R-VQS is featured on the five Resona 7 systems our hospital just purchased and installed," said Paul Lucas, MD, director of the Vascular department at Mercy Medical Center in Baltimore, Maryland. "We are excited about this industry first tool and what it could mean for vascular clinicians in helping to diagnose disease. To that end, we are partnering with Mindray to research the potential of this powerful technology."

Arterial stiffness is a benchmark of aging, and classic cardiovascular risk factors can hasten this process. Healthcare's recent focus on preventive care, has led to a growing interest in non-invasive evaluation of arterial stiffness.

Pulse Wave Velocity (PWV) and Stiffness coefficient are accepted methods of quantifying Arterial Stiffness (AS). R-VQS, enabled by ZST, uses channel domain data to accurately calculate PWV and AS by automatically detecting the movement and diameter of intimal surfaces over six cardiac cycles. When this data is combined with the manual input of blood pressure, it yields a quantifiable report.

"In 2015, the American Heart Association published a statement to encourage further standardization of arterial stiffness measurements," said Dr. Lucas. "There are several methodologies that are currently used to reflect arterial stiffness. We believe R-VQS could be a new and more automated method for this important measurement and look forward to our forthcoming research in support of this."

About Mindray Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China; North American headquarters in Mahwah, New Jersey; and multiple development facilities and offices in major international markets including an ultrasound Innovation Center in Silicon Valley and R&D office in Seattle. Mindray supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://www.mindray.com.

 

SOURCE Mindray



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store